On the other hand, dysregulation of lncRNA control circuits can potentially effect the development of disease (38): a very prominent example of this in cardiovascular diseases is the lncRNA ANRIL, which is a key effector of 9p21 in atherosclerotic risk and cardiovascular events (38–40). This evidence concerns the gene CDKN2B-AS1 and cardiovascular disorder.